MX4348E - Procedimiento para la preparacion de analogos de cefalosporina - Google Patents

Procedimiento para la preparacion de analogos de cefalosporina

Info

Publication number
MX4348E
MX4348E MX775582U MX558277U MX4348E MX 4348 E MX4348 E MX 4348E MX 775582 U MX775582 U MX 775582U MX 558277 U MX558277 U MX 558277U MX 4348 E MX4348 E MX 4348E
Authority
MX
Mexico
Prior art keywords
procedure
preparation
cephalosporin analogs
cephalosporin
analogs
Prior art date
Application number
MX775582U
Other languages
English (en)
Spanish (es)
Inventor
Masayuki Narisada
Wataru Nagata
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3340176A external-priority patent/JPS52122386A/ja
Priority claimed from JP5029576A external-priority patent/JPS52133997A/ja
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of MX4348E publication Critical patent/MX4348E/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX775582U 1976-03-25 1977-03-25 Procedimiento para la preparacion de analogos de cefalosporina MX4348E (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3340176A JPS52122386A (en) 1976-03-25 1976-03-25 Cephalosporin analogous compounds as antibacterials
JP5029576A JPS52133997A (en) 1976-04-30 1976-04-30 Cephalosporin antibiotics

Publications (1)

Publication Number Publication Date
MX4348E true MX4348E (es) 1982-04-05

Family

ID=26372085

Family Applications (1)

Application Number Title Priority Date Filing Date
MX775582U MX4348E (es) 1976-03-25 1977-03-25 Procedimiento para la preparacion de analogos de cefalosporina

Country Status (19)

Country Link
AR (1) AR224606A1 (fr)
BG (1) BG31074A3 (fr)
CY (1) CY1158A (fr)
DD (1) DD129792A5 (fr)
DE (1) DE2713370C2 (fr)
DK (1) DK161331C (fr)
ES (5) ES457174A1 (fr)
GR (1) GR61146B (fr)
HK (1) HK46882A (fr)
HU (1) HU172720B (fr)
IE (1) IE44794B1 (fr)
IL (1) IL51743A (fr)
MX (1) MX4348E (fr)
NO (2) NO158505C (fr)
NZ (1) NZ183687A (fr)
PT (1) PT66346B (fr)
RO (2) RO71742A (fr)
SE (1) SE443143B (fr)
YU (2) YU44039B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1557552A (en) * 1977-02-15 1979-12-12 Shionogi & Co 1 oxadethiacepham compounds
US4252953A (en) * 1979-05-01 1981-02-24 Eli Lilly And Company Antibiotic crystalline epimer
JPS60123490A (ja) * 1983-12-07 1985-07-02 Shionogi & Co Ltd マロニルオキサセフェムカルボン酸誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL178005C (nl) * 1972-11-06 1986-01-02 Merck & Co Inc Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking, alsmede werkwijze ter bereiding van een cefalosporine-antibioticum.
US3962232A (en) * 1973-11-05 1976-06-08 Eli Lilly And Company 7-methoxycephalosporins
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives

Also Published As

Publication number Publication date
DE2713370A1 (de) 1977-09-29
HU172720B (hu) 1978-11-28
HK46882A (en) 1982-11-19
DE2713370C2 (de) 1994-04-21
ES469286A1 (es) 1979-09-16
YU44038B (en) 1990-02-28
NZ183687A (en) 1979-01-11
YU173883A (en) 1983-12-31
YU173783A (en) 1983-12-31
DD129792A5 (de) 1978-02-08
RO78228A (fr) 1982-02-01
SE7703325L (sv) 1977-09-26
CY1158A (en) 1983-01-28
SE443143B (sv) 1986-02-17
DK161331B (da) 1991-06-24
NO862107L (no) 1977-09-27
IE44794L (en) 1977-09-25
ES469287A1 (es) 1979-09-16
GR61146B (en) 1978-09-27
NO158505B (no) 1988-06-13
PT66346B (en) 1978-08-16
YU44039B (en) 1990-02-28
AR224606A1 (es) 1981-12-30
RO71742A (fr) 1982-02-26
PT66346A (en) 1977-04-01
DK161331C (da) 1991-12-09
ES457174A1 (es) 1978-08-16
NO771023L (no) 1977-09-27
DK131277A (da) 1977-09-26
ES469284A1 (es) 1978-11-16
ES469285A1 (es) 1979-09-16
IL51743A (en) 1980-10-26
IE44794B1 (en) 1982-04-07
BG31074A3 (en) 1981-10-15
NO158505C (no) 1988-09-21

Similar Documents

Publication Publication Date Title
AR222007A1 (es) Procedimiento para la preparacion de nuevos hentriacontapeptidos
AR215930A1 (es) Procedimiento para la preparacion de compuestos 2-fenil-3-benzoil-benzotiofeno
MX5328E (es) Proceso para la preparacion de analogos de tiadiazolil cefalosporina
MX4089E (es) Procedimiento mejorado para la preparacion de n-fosfonometilglicina
AR220683A1 (es) Procedimiento para la preparacion de m-fenoxibenzaldehido
AR215875A1 (es) Procedimiento para la prepararacion de meta-fenoxi-benzaldehido
AR211887A1 (es) Procedimiento para la preparacion de derivados de endolizina
MX143488A (es) Procedimiento para la preparacion de resorcinas
MX4664E (es) Procedimiento mejorado para la preparacion de derivados de n-fosfonometilglicina
MX148583A (es) Procedimiento mejorado para la preparacion de un compuesto de organoestano
MX5388E (es) Proceso para la preparacion de compuestos de cefalosporina
MX5586E (es) Procedimiento para la preparacion de derivados de cefalosporina
AR213831A1 (es) Procedimiento para la preparacion de 11-desoxi-16-aril-omega-tetranorprostaglandina
MX4796E (es) Procedimiento para la preparacion de derivados de 2-iminotiazolina
AR213430A1 (es) Procedimiento para la preparacion de nuevas n-cianoalquil-p-halofenoxi-isobutiramidas
MX143639A (es) Procedimiento para la preparacion de compuestos disazoicos tetrarreactivos
MX4133E (es) Procedimiento para la preparacion de n-tetrahidrofurfuril-noroximorfonas diastereoisomeras
AR217664A1 (es) Procedimiento para la preparacion de derivados de oleandomicina
AR209498A1 (es) Procedimiento para la preparacion de l-piroglutamil-l-pronilamida
MX144780A (es) Procedimiento mejorado para la preparacion de epoxidos
MX4750E (es) Procedimiento para la preparacion de gamma-pironas
MX4813E (es) Procedimiento para preparar analogos de prostaglandinas
AR230642A1 (es) Procedimiento para la preparacion de un indoledihidroindolcarboxamida dimerica
MX147640A (es) Procedimiento para la preparacion de compuestos de 4 6-5-beta-sulfatoetilsulfonil-2-amino-fenol
AR216660A1 (es) Procedimiento para la obtencion de compuestos de fenilaminometilimidazolina